BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3259478)

  • 21. Growth of pancreatic foci and development of pancreatic cancer with a single dose of azaserine in the rat.
    Roebuck BD; Baumgartner KJ; Longnecker DS
    Carcinogenesis; 1987 Dec; 8(12):1831-5. PubMed ID: 3499996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of castration and hormone replacement on azaserine-induced pancreatic carcinogenesis in male and female Fischer rats.
    Lhoste EF; Roebuck BD; Brinck-Johnsen T; Longnecker DS
    Carcinogenesis; 1987 May; 8(5):699-703. PubMed ID: 3581428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic effects of camostate on growth and endocrine function of the pancreas in streptozotocin-induced diabetic rats.
    Kogire M; Inoue K; Gu Y; Uchida K; Imamura M
    Proc Soc Exp Biol Med; 1993 Nov; 204(2):201-5. PubMed ID: 8415777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of trypsin inhibitor on the pancreas and small intestine of mice.
    Ge YC; Morgan RG
    Br J Nutr; 1993 Jul; 70(1):333-45. PubMed ID: 8399113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
    Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
    Ann N Y Acad Sci; 1994 Mar; 713():439-41. PubMed ID: 8018216
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of a specific serine protease inhibitor on the rat pancreas. II. Influence of camostate on the endocrine pancreas.
    Göke B; Siegel EG; Stöckmann F; Lankisch PG; Creutzfeldt W
    Digestion; 1985; 31(2-3):128-35. PubMed ID: 3888752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histochemical studies on gamma-glutamyltranspeptidase activity of pancreatic acinar cell lesions induced by 4-hydroxyaminoquinoline 1-oxide and/or azaserine in rats.
    Murata Y; Denda A; Obara T; Yokose Y; Konishi Y
    Exp Pathol; 1987; 32(1):41-53. PubMed ID: 2889612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of ornithine decarboxylase and polyamines in camostate (Foy-305)-induced pancreatic growth in rats.
    Löser C; Fölsch UR; Cleffmann U; Nustede R; Creutzfeldt W
    Digestion; 1989; 43(1-2):98-112. PubMed ID: 2509268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic and biochemical effects of azaserine in inbred Wistar/Lewis rats and noninbred CD-1 mice.
    Roebuck BD; Lilja HS; Curphey TJ; Longnecker DS
    J Natl Cancer Inst; 1980 Aug; 65(2):383-9. PubMed ID: 6931255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effect of lorglumide on pancreatic growth stimulated by camostate in rat and hamster.
    Douglas BR; Woutersen RA; Jansen JB; Rovati LC; Lamers CB
    Life Sci; 1990; 46(4):281-6. PubMed ID: 2304371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary modulation of pancreatic carcinogenesis: calories and energy expenditure.
    Craven-Giles T; Tagliaferro AR; Ronan AM; Baumgartner KJ; Roebuck BD
    Cancer Res; 1994 Apr; 54(7 Suppl):1964s-1968s. PubMed ID: 8137321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of putative preneoplastic foci in exocrine pancreas of rats and hamsters. I. Interaction of dietary fat and ethanol.
    Woutersen RA; van Garderen-Hoetmer A; Bax J; Feringa AW; Scherer E
    Carcinogenesis; 1986 Sep; 7(9):1587-93. PubMed ID: 2943527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-dependent influence of octreotide on stimulated pancreatic growth in the postnatal period of rats.
    Kisfalvi K; Friess H; Büchler MW; Tulassay Z; Varga G; Papp M
    Eur J Gastroenterol Hepatol; 1996 Jan; 8(1):69-74. PubMed ID: 8900912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
    Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
    Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
    Herzig KH; May D; Louie DS; Takahashi T; Göke B; Owyang C
    Digestion; 1990; 46 Suppl 2():195-201. PubMed ID: 1702070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of growth and cell turnover of preneoplastic lesions and of prostaglandin levels in rat pancreas by dietary fish oil.
    Appel MJ; Woutersen RA
    Carcinogenesis; 1994 Oct; 15(10):2107-12. PubMed ID: 7955040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine and exocrine pancreatic function after camostate-induced growth of the organ.
    von Schönfeld J; Rünzi M; Goebell H; Müller MK
    Experientia; 1995 Jun; 51(6):556-60. PubMed ID: 7607295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas.
    Lhoste EF; Longnecker DS
    Cancer Res; 1987 Jun; 47(12):3273-7. PubMed ID: 3581068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.